|Day Low/High||0.32 / 0.34|
|52 Wk Low/High||0.31 / 2.29|
Former hedge funder and biotech CEO Martin Shkreli finds himself in limbo as a criminal jury now decides if allegations of fraud will put him in orange coveralls.
Partnership to Launch at the EULAR (European League Against Rheumatism) Congress in Madrid, Spain June 14-17
Topline trial results announcement expected early Q3 2017
Presentation on Wednesday, May 24, 2017 at 09:00 AM Pacific Time
Data suggests safety and potential sustained efficacy in post prostatectomy patients failing pharmacologic intervention
Cytori Therapeutics stock is sinking after the biotech company priced a stock offering at steep discount.
Presentation on February 15, 2017 at 11:15 AM Eastern Time
Here's how biotech and healthcare stocks are moving ahead of market's open.